Severe raltegravir-associated rhabdomyolysis: a case report and review of the literature-Reference-Cited by-同舟云学术

Severe raltegravir-associated rhabdomyolysis: a case report and review of the literature

Published:2010-11 Issue:11 Volume:21 Page:783-785
ISSN:0956-4624
Container-title:International Journal of STD & AIDS
language:en
Short-container-title:Int J STD AIDS

Author:

Croce F¹,Vitello P¹,Dalla Pria A¹,Riva A¹,Galli M¹,Antinori S¹

Affiliation:

1. Department of Clinical Sciences, Section of Infectious Diseases and Immunopathology, University of Milan, L Sacco Hospital, Milan, Italy

Abstract

Raltegravir (RAL), an HIV integrase inhibitor, may uncommonly induce an increase of serum creatine kinase (CK) both in naïve and antiretroviral (ARV)-experienced HIV-positive patients. We report the case of severe rhabdomyolysis requiring hospitalization in an ARV-experienced HIV/hepatitis C co-infected patient treated with a RAL-containing drug regimen. Factors favouring a severe clinical occurrence of RAL-induced rhabdomyolysis from cases reported in literature are described.

Publisher

SAGE Publications

Subject

Infectious Diseases,Pharmacology (medical),Public Health, Environmental and Occupational Health,Dermatology

Link

http://journals.sagepub.com/doi/pdf/10.1258/ijsa.2010.010246

Reference9 articles.

1. Raltegravir with Optimized Background Therapy for Resistant HIV-1 Infection

2. Safety and efficacy of raltegravir-based versus efavirenz-based combination therapy in treatment-naive patients with HIV-1 infection: a multicentre, double-blind randomised controlled trial

3. Severe rhabdomyolysis associated with raltegravir use

4. A case of rhabdomiolysis associated with raltegravir use

Cited by 29 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Role of the pharmacist caring for people at risk of or living with HIV in Canada;Canadian Pharmacists Journal / Revue des Pharmaciens du Canada;2024-08-02

2. A suspected case of hyponatraemia induced rhabdomyolysis: a case report;BMC Nephrology;2022-05-11

3. HIV-1 Integrase Inhibitors: A Comparative Review of Efficacy and Safety;Drugs;2020-08-29

4. Severe rhabdomyolysis and acute asymptomatic pancreatitis following the concomitant use of Biktarvy in the setting of hyperosmolar diabetic crisis;BMJ Case Reports;2020-07

5. Acute myocarditis after switch to dolutegravir;AIDS;2019-11-01